Weight management is one of the most researched, most marketed, and most misunderstood areas of health. We focus on what the clinical data actually supports — and we’re honest about where the evidence gets complicated.
Weight Science is TutelaMedical’s coverage area for evidence-based weight management research, GLP-1 science, metabolic health, and the interventions that published data supports. This isn’t a diet blog. We don’t publish meal plans or workout routines. What we do is translate the clinical research into information you can use to evaluate the products, programs, and protocols competing for your money and your trust.
What We Cover — and Why
GLP-1 Medications & Telehealth Access
GLP-1 receptor agonists — semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) — represent the most significant pharmacological development in weight management in decades. The clinical data on these medications is strong: average weight loss of 15-20% of body weight in controlled trials, with meaningful improvements in cardiometabolic risk markers.
But the access landscape is complex. Brand-name medications cost over $1,000 monthly without insurance. Compounded alternatives are available through telehealth platforms at a fraction of the cost — but compounded medications are not FDA-approved versions, and not all compounding pharmacies operate at the same quality standard. Insurance coverage varies widely and changes frequently.
We cover this space because the decisions involved are consequential and the information environment is cluttered with marketing from platforms competing for patients. Our Telehealth Evaluations assess specific platforms. Our Weight Science articles examine the underlying evidence, safety considerations, and access dynamics.
Metabolic Health Research
Weight management doesn’t happen in isolation. It intersects with insulin sensitivity, thyroid function, hormonal balance, sleep quality, gut microbiome composition, and stress physiology. We cover research developments in these areas when they have practical relevance to weight management decisions — not as theoretical science, but as information that helps you evaluate whether a product or protocol is addressing a real mechanism or exploiting a buzzword.
Supplement Interventions for Weight Management
The weight loss supplement category is one of the most crowded and most overpromised in the entire wellness industry. Thousands of products compete with claims that range from modestly supported to entirely fabricated. We evaluate these products through our Research Reviews process, and we cover the underlying science here in Weight Science.
The honest truth: no supplement replicates the efficacy of caloric deficit, physical activity, or GLP-1 medications. Some compounds — berberine, green tea extract (EGCG), glucomannan, capsaicin — have published evidence supporting modest effects on specific metabolic pathways. But “modest effects on specific pathways” is not what most supplement marketing promises. We bridge that gap between what the ingredients can do and what the products claim to do.
Non-Prescription GLP-1 Support Products
A growing category of supplements and wellness products is marketed around GLP-1 pathways — products claiming to “naturally boost GLP-1,” “support GLP-1 response,” or provide “GLP-1 activation.” This category requires particularly careful analysis, because the marketing language intentionally creates association with prescription GLP-1 medications like Wegovy and Ozempic.
We are clear and consistent on this point: non-prescription products marketed as GLP-1 support do not work the same way as prescription GLP-1 receptor agonists. Some contain ingredients (like berberine) that have published effects on metabolic pathways, but the magnitude of effect is not comparable to injectable semaglutide or tirzepatide. We evaluate these products on their own merits — which means assessing what they can realistically deliver, not what the GLP-1 branding implies.
Our Approach to Weight Science Content
We report the evidence, including the uncomfortable parts. Not every study tells the story the supplement industry wants to hear. When a systematic review shows that a popular ingredient produces only marginal weight differences versus placebo, we report that — because a reader making a purchasing decision deserves the full picture, not a curated one.
We distinguish between statistical significance and practical significance. A study can show a “statistically significant” difference of 1.2 pounds over 12 weeks. That’s a real finding. It’s also not a meaningful difference for someone hoping to lose 30 pounds. We translate research outcomes into terms that matter for real-world decisions.
We acknowledge what we don’t know. Weight management research is incomplete. Individual variation in treatment response is enormous. Genetic, hormonal, behavioral, and environmental factors interact in ways that no single study fully captures. When the evidence is limited or conflicting, we say so — because acknowledging uncertainty is more useful than manufacturing false confidence.
Key Topics
GLP-1 Medications Explained — How semaglutide and tirzepatide work, what the clinical trial data shows, side effect profiles, and what “average weight loss of 15-20%” actually means in practice.
Compounded vs. Brand-Name GLP-1 Medications — The regulatory, quality, and cost differences between FDA-approved brand-name medications and compounded alternatives available through telehealth. What you need to know before choosing.
Metabolic Health & Blood Sugar — Insulin sensitivity, metabolic adaptation, blood sugar management compounds, and the factors that influence weight management outcomes beyond simple caloric math.
Weight Loss Supplements — What the clinical data actually supports for popular weight loss ingredients: berberine, EGCG, glucomannan, CLA, capsaicin, and others. Realistic expectations based on published effect sizes.